142 related articles for article (PubMed ID: 33508619)
21. Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Fraietta JA; Lacey SF; Orlando EJ; Pruteanu-Malinici I; Gohil M; Lundh S; Boesteanu AC; Wang Y; O'Connor RS; Hwang WT; Pequignot E; Ambrose DE; Zhang C; Wilcox N; Bedoya F; Dorfmeier C; Chen F; Tian L; Parakandi H; Gupta M; Young RM; Johnson FB; Kulikovskaya I; Liu L; Xu J; Kassim SH; Davis MM; Levine BL; Frey NV; Siegel DL; Huang AC; Wherry EJ; Bitter H; Brogdon JL; Porter DL; June CH; Melenhorst JJ
Nat Med; 2021 Mar; 27(3):561. PubMed ID: 33547459
[No Abstract] [Full Text] [Related]
22. Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid Leukemia.
Marjoncu D; Andrick B
J Adv Pract Oncol; 2020; 11(1):104-108. PubMed ID: 33542854
[TBL] [Abstract][Full Text] [Related]
23. The Interplay of Exosomes and NK Cells in Cancer Biology.
Batista IA; Quintas ST; Melo SA
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530529
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
[TBL] [Abstract][Full Text] [Related]
25. CD123 Is Consistently Expressed on
Perriello VM; Gionfriddo I; Rossi R; Milano F; Mezzasoma F; Marra A; Spinelli O; Rambaldi A; Annibali O; Avvisati G; Di Raimondo F; Ascani S; Falini B; Martelli MP; Brunetti L
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33525388
[No Abstract] [Full Text] [Related]
26. Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia.
Kim HJ; Ryu H; Choi HK; Song JY; Hwang SG; Ahn J
Anticancer Res; 2021 Feb; 41(2):731-737. PubMed ID: 33517277
[TBL] [Abstract][Full Text] [Related]
27. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.
Liu J; Yang S; Cao B; Zhou G; Zhang F; Wang Y; Wang R; Zhu L; Meng Y; Hu C; Liang H; Lin X; Zhu K; Chen G; Luo KQ; Di L; Zhao Q
J Hematol Oncol; 2021 Jan; 14(1):21. PubMed ID: 33514401
[TBL] [Abstract][Full Text] [Related]
28. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
29. The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.
Gonzalez-Lugo JD; Chakraborty S; Verma A; Shastri A
Semin Hematol; 2021 Jan; 58(1):56-65. PubMed ID: 33509444
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Doraiswamy A; Shah MR; Bannerji R
Curr Hematol Malig Rep; 2021 Feb; 16(1):72-81. PubMed ID: 33619641
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia: current progress and future directions.
Kantarjian H; Kadia T; DiNardo C; Daver N; Borthakur G; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F
Blood Cancer J; 2021 Feb; 11(2):41. PubMed ID: 33619261
[TBL] [Abstract][Full Text] [Related]
32.
Naseem S; Binota J; Varma N; Virk H; Varma S; Malhotra P
Int J Hematol Oncol Stem Cell Res; 2021 Jan; 15(1):15-26. PubMed ID: 33613897
[No Abstract] [Full Text] [Related]
33. Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells.
Gauthier M; Laroye C; Bensoussan D; Boura C; Decot V
Crit Rev Oncol Hematol; 2021 Apr; 160():103261. PubMed ID: 33607229
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometry reveals the nuances of clonal haematopoiesis.
Hasserjian RP
Br J Haematol; 2021 Mar; 192(6):949-950. PubMed ID: 33605429
[No Abstract] [Full Text] [Related]
35. Maintenance Therapy in AML.
Reville PK; Kadia TM
Front Oncol; 2020; 10():619085. PubMed ID: 33604298
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Röllig C; Serve H; Noppeney R; Hanoun M; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Müller-Tidow C; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Frickhofen N; Kullmer J; Kaiser U; Kiani A; Link H; Geer T; Reichle A; Junghanß C; Repp R; Meinhardt A; Dürk H; Klut IM; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Platzbecker U; Schetelig J; Kramer M; Berdel WE; Ehninger G;
Leukemia; 2021 Sep; 35(9):2517-2525. PubMed ID: 33603142
[TBL] [Abstract][Full Text] [Related]
37. Syngeneic leukemia models using lentiviral transgenics.
Keinan N; Scharff Y; Goldstein O; Chamo M; Ilic S; Gazit R
Cell Death Dis; 2021 Feb; 12(2):193. PubMed ID: 33602907
[TBL] [Abstract][Full Text] [Related]
38. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
Di Genua C; Nerlov C
Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
[TBL] [Abstract][Full Text] [Related]
39. Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche.
Yasuda T; Ishimoto T; Baba H
Regen Ther; 2021 Jun; 17():8-12. PubMed ID: 33598509
[TBL] [Abstract][Full Text] [Related]
40. Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy.
Chen R; Okeyo-Owuor T; Patel RM; Casey EB; Cluster AS; Yang W; Magee JA
Cell Rep; 2021 Feb; 34(7):108751. PubMed ID: 33596429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
